Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Venofer Articles

US FTC challenges Fresenius deal

22 September 2008

US FTC challenges Fresenius deal

22 September 2008

Galenica profit up 50% in first half of 2008

1 September 2008

Japan stock market week to July 14, 2008

21 July 2008

Fresenius signs two licensing deals for its IV Iron products

14 July 2008

Daiichi Sankyo streamlining leads to fall in revenue but 24% increase in profit

26 May 2008

Japan's Daiichi Sankyo aims for sales of 960B yen in 2009, by growing oversees

26 February 2007

Q-Med launches Cosmofer in Sweden

17 July 2006

NeoRecormon and Venofer show potential in anemia trial

26 June 2006

UK's MHRA acts on misleading drug ads

13 February 2006

Galenica sees 1st-half sales/profits growth

10 September 2001

Galenica wins FDA OK for Venofer

16 November 2000

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS